High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy

BACKGROUND: Ovarian carcinoma (OC) is the fifth most common female cancer and mostly diagnosed at an advanced stage. Surgical debulking is usually followed by adjuvant platinum-based chemotherapy. Only few biomarkers are known to be related to chemosensitivity. OX40 is a TNF receptor member and expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramser, Michaela, Eichelberger, Simone, Däster, Silvio, Weixler, Benjamin, Kraljević, Marko, Mechera, Robert, Tampakis, Athanasios, Delko, Tarik, Güth, Uwe, Stadlmann, Sylvia, Terracciano, Luigi, Droeser, Raoul A., Singer, Gad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903007/
https://www.ncbi.nlm.nih.gov/pubmed/29661166
http://dx.doi.org/10.1186/s12885-018-4339-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903007/
https://www.ncbi.nlm.nih.gov/pubmed/29661166
http://dx.doi.org/10.1186/s12885-018-4339-0

Ejemplares similares